Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultra-long versus long GnRH agonist down-regulation in IVF/ICSI for adenomyosis
2019-001830-32Phase 3Terminated
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of triptorelin and estradiol in adenomyosis and female infertility (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Live birth after first or second IVF/ICSI attempt. Started Jul 2019; status: terminated.
02
Drugs
triptorelinestradiol
03
Conditions
adenomyosisfemale infertility
Beyond the preview
Go deeper on 2019-001830-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001830-32.